from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2160c/-

LFCtreatmentdescriptionclass of inhibitor

-1.481

Amikacinug/mL Amikacintranslation

-1.508

Cap5-10ug/mL Capreomycintranslation

-1.515

Rox10-50 ug/mL Roxithromycintranslation

-0.801

SM2-5 ug/mL Streptomycintranslation

-0.304

Tet5-10 ug/mL Tetracyclinetranslation

-0.880

Rif0.2-5ug/mL Rifampicintranscription

-0.077

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.669

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.514

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.166

CPZ10-50 ug/mL Chlorpromazinerespiration

0.574

Clofazimine10-13 ug/mL Clofaziminerespiration

0.242

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.157

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.983

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.557

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.442

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.046

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.044

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.672

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.468

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.205

KCN5-20 ug/mL Potassium cyaniderespiration

-0.067

NaN30.2-2 mM Sodium aziderespiration

0.724

Nigericin50 uM Nigericinrespiration

1.011

TRC10-150 ug/mL Triclosanrespiration

0.414

TRZ10-25 ug/mL Thioridazinerespiration

0.376

Valinomycin0.5-10 uM Valinomycinrespiration

0.123

ZnSO42 mM ZnSO4respiration

-0.368

menadione6-10 ug/mL Menadionerespiration

0.049

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.648

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.135

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.386

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.438

NRP_1Non-replicating persistence stage 1dosRassociated

-0.376

Amp0.2mg/mL AmpicillincellWall

-0.626

Cephalexin20-100 ug/mL CephalexincellWall

-1.037

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.514

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.404

EMB10-20 ug/mL EthambutolcellWall

0.370

Eta12-40 ug/mL EthionamidecellWall

0.349

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.304

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.497

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.138

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.766

BZA0.12 mg/mL BenzamidearomaticAmides

0.574

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.490

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.940

H2O24 mM hydrogen peroxideDNAdamaging

-0.813

Levo10 ug/mL LevofloxacinDNAdamaging

-1.040

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.321

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.185

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.903

UVUV-irradiationDNAdamaging

-0.172

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.036

Antimycin12.5-50 ug/mL Antimycin A?

-0.316

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.967

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.489

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.251

PA8240.2-2 ug/mL PA-824?

0.103

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.269

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.465

Verapamil50 uM Verapamil?

-0.686

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.475

methoxatin10-20 ug/mL Methoxatin?